Rani Therapeutics Holdings RANI
NASDAQ RANI
$0.59 -0.02 (-2.88%)
At close: Oct 22, 2026 · 4:00 PM EDT

Rani Therapeutics Holdings (RANI) Preferred Shares (2021)

Updated

Rani Therapeutics Holdings (RANI) posted Preferred Shares of $191.03 million for Q2 2021.

Analysis

Rani Therapeutics Holdings (RANI) Preferred Shares (2021) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Preferred Shares (Qtr)
1 Eli Lilly 1,165.22 Bn 1,133.81 Bn 19.71 Bn -
2 Johnson & Johnson 646.28 Bn 566.14 Bn 17.30 Bn -
3 AbbVie 503.17 Bn 476.28 Bn 12.70 Bn -
4 Merck 365.23 Bn 319.60 Bn 12.21 Bn -
5 Novartis Ag 302.66 Bn 266.65 Bn 11.24 Bn -
6 Astrazeneca 267.39 Bn 241.08 Bn 12.86 Bn -
7 Amgen 241.61 Bn 197.01 Bn 7.24 Bn -
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn -
9 Pfizer 172.91 Bn 119.55 Bn 10.94 Bn -
10 Rani Therapeutics Holdings 109.55 Mn -10.01 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2021 191.03 Mn
API Access

Rani Therapeutics Holdings Preferred Shares API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=preferred-shares&ticker=RANI&period=max&api_key=YOUR_API_KEY